New therapeutics that antagonize endothelin: promises and frustrations
Author:
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.nature.com/articles/nrd962.pdf
Reference249 articles.
1. Yanagisawa, M. et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332, 411–415 (1988). This seminal article describes the discovery of ET-1, and represents the starting point for more than 14,000 subsequent studies elucidating pathophysiological roles of the peptide in normal and disease conditions.
2. Rubanyi, G. M. & Vanhoutte, P. M. Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium. J. Physiol. 364, 45–56 (1985).
3. Levin, E. R. Endothelins. N. Engl. J. Med. 333, 356–363 (1995).
4. Inoue, A. et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl Acad. Sci. USA 86, 2863–2867 (1989). The authors report a pivotal observation of the existence of three components of the ET family discovered by screening a genomic DNA library with synthetic oligonucleotides encoding a portion of the ET sequence.
5. Saida, K., Mitsui, Y. & Ishida, I. A novel peptide, vasoactive intestinal contractor, of a new (endothelin) peptide family. Molecular cloning, expression and biological activity. J. Biol. Chem. 264, 14613–14616 (1989).
Cited by 140 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment;Drug Design, Development and Therapy;2024-09
2. The Tetraspanin Tspan8 Associates with Endothelin Converting Enzyme ECE1 and Regulates Its Activity;Cancers;2023-09-27
3. Profile of Molecular Markers of Cardiac Fibrosis in Rats Exposed to Different Doxorubicin Doses;Journal of Evolutionary Biochemistry and Physiology;2023-03
4. MOLECULAR MARKERS PROFILE OF FIBROSIS IN RATS EXPOSED TO DIFFERENT DOSES OF DOXORUBICIN;Журнал эволюционной биохимии и физиологии;2023-03-01
5. Modeling Doxorubicin-Induced Cardiomyopathy With Fibrotic Myocardial Damage in Wistar Rats;Cardiology Research;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3